Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 336

1.

Detection of Novel Fusion Transcript VTI1A-CFAP46 in Hepatocellular Carcinoma.

Tsuge S, Saberi B, Cheng Y, Wang Z, Kim A, Luu H, Abraham JM, Ybanez MD, Hamilton JP, Selaru FM, Villacorta-Martin C, Schlesinger F, Philosophe B, Cameron AM, Zhu Q, Anders R, Gurakar A, Meltzer SJ.

Gastrointest Tumors. 2019 Aug;6(1-2):11-27. doi: 10.1159/000496795. Epub 2019 Apr 10.

PMID:
31602373
2.

Master transcription factors form interconnected circuitry and orchestrate transcriptional networks in oesophageal adenocarcinoma.

Chen L, Huang M, Plummer J, Pan J, Jiang YY, Yang Q, Silva TC, Gull N, Chen S, Ding LW, An O, Yang H, Cheng Y, Said JW, Doan N, Dinjens WN, Waters KM, Tuli R, Gayther SA, Klempner SJ, Berman BP, Meltzer SJ, Lin DC, Koeffler HP.

Gut. 2019 Aug 13. pii: gutjnl-2019-318325. doi: 10.1136/gutjnl-2019-318325. [Epub ahead of print]

PMID:
31409603
3.

Krüppel-like Factor 5 Promotes Sonic Hedgehog Signaling and Neoplasia in Barrett's Esophagus and Esophageal Adenocarcinoma.

Ng CK, Ma K, Cheng Y, Miyashita T, Harmon JW, Meltzer SJ.

Transl Oncol. 2019 Aug 8;12(11):1432-1441. doi: 10.1016/j.tranon.2019.07.006. [Epub ahead of print]

4.

Targeting the Hedgehog Pathway Using Itraconazole to Prevent Progression of Barrett's Esophagus to Invasive Esophageal Adenocarcinoma.

Kelly RJ, Ansari AM, Miyashita T, Zahurak M, Lay F, Ahmed AK, Born LJ, Pezhouh MK, Salimian KJ, Ng C, Matsangos AE, Stricker-Krongrad AH, Mukaisho KI, Marti GP, Chung CH, Canto MI, Rudek MA, Meltzer SJ, Harmon JW.

Ann Surg. 2019 Jul 8. doi: 10.1097/SLA.0000000000003455. [Epub ahead of print]

PMID:
31290765
5.

Synthetic circular multi-miR sponge simultaneously inhibits miR-21 and miR-93 in esophageal carcinoma.

Wang Z, Ma K, Cheng Y, Abraham JM, Liu X, Ke X, Wang Z, Meltzer SJ.

Lab Invest. 2019 Oct;99(10):1442-1453. doi: 10.1038/s41374-019-0273-2. Epub 2019 Jun 19.

PMID:
31217510
6.

Evaluation of Salivary Exosomal Chimeric GOLM1-NAA35 RNA as a Potential Biomarker in Esophageal Carcinoma.

Lin Y, Dong H, Deng W, Lin W, Li K, Xiong X, Guo Y, Zhou F, Ma C, Chen Y, Ren H, Yang H, Dai N, Ma L, Meltzer SJ, Yeung SJ, Zhang H.

Clin Cancer Res. 2019 May 15;25(10):3035-3045. doi: 10.1158/1078-0432.CCR-18-3169. Epub 2019 Feb 11.

PMID:
30745298
7.

Methylation Biomarker Panel Performance in EsophaCap Cytology Samples for Diagnosing Barrett's Esophagus: A Prospective Validation Study.

Wang Z, Kambhampati S, Cheng Y, Ma K, Simsek C, Tieu AH, Abraham JM, Liu X, Prasath V, Duncan M, Stark A, Trick A, Tsai HL, Wang H, He Y, Khashab MA, Ngamruengphong S, Shin EJ, Wang TH, Meltzer SJ.

Clin Cancer Res. 2019 Apr 1;25(7):2127-2135. doi: 10.1158/1078-0432.CCR-18-3696. Epub 2019 Jan 22.

PMID:
30670490
8.

Novel circular RNA NF1 acts as a molecular sponge, promoting gastric cancer by absorbing miR-16.

Wang Z, Ma K, Pitts S, Cheng Y, Liu X, Ke X, Kovaka S, Ashktorab H, Smoot DT, Schatz M, Wang Z, Meltzer SJ.

Endocr Relat Cancer. 2018 Dec 1. pii: ERC-18-0478.R1. doi: 10.1530/ERC-18-0478. [Epub ahead of print]

PMID:
30576282
9.

Inhibition of miR‑194 suppresses the Wnt/β‑catenin signalling pathway in gastric cancer.

Peng Y, Zhang X, Lin H, Deng S, Huang Y, Qin Y, Feng X, Yan R, Zhao Y, Cheng Y, Wei Y, Wang J, Chen W, Fan X, Ashktorab H, Smoot D, Meltzer SJ, Li S, Zhang Z, Jin Z.

Oncol Rep. 2018 Dec;40(6):3323-3334. doi: 10.3892/or.2018.6773. Epub 2018 Oct 8.

10.

A Pilot Randomized-Controlled Trial on the Effect of CPAP Treatment on Glycemic Control in Gestational Diabetes: Study Design and Methods.

Pamidi S, Meltzer SJ, Garfield N, Lavigne L, Olha A, Khalyfa A, Benedetti A, Tremblay G, Gagnon R, Rey E, Dasgupta K, Kimoff RJ.

Front Endocrinol (Lausanne). 2018 Nov 16;9:659. doi: 10.3389/fendo.2018.00659. eCollection 2018.

11.

Epigenetic alterations of a novel antioxidant gene SLC22A3 predispose susceptible individuals to increased risk of esophageal cancer.

Xiong JX, Wang YS, Sheng J, Xiang D, Huang TX, Tan BB, Zeng CM, Li HH, Yang J, Meltzer SJ, Mori Y, Qin YR, Guan XY, Fu L.

Int J Biol Sci. 2018 Sep 7;14(12):1658-1668. doi: 10.7150/ijbs.28482. eCollection 2018.

12.

Synthetic Circular RNA Functions as a miR-21 Sponge to Suppress Gastric Carcinoma Cell Proliferation.

Liu X, Abraham JM, Cheng Y, Wang Z, Wang Z, Zhang G, Ashktorab H, Smoot DT, Cole RN, Boronina TN, DeVine LR, Talbot CC Jr, Liu Z, Meltzer SJ.

Mol Ther Nucleic Acids. 2018 Dec 7;13:312-321. doi: 10.1016/j.omtn.2018.09.010. Epub 2018 Sep 22.

13.

Modeling Wnt signaling by CRISPR-Cas9 genome editing recapitulates neoplasia in human Barrett epithelial organoids.

Liu X, Cheng Y, Abraham JM, Wang Z, Wang Z, Ke X, Yan R, Shin EJ, Ngamruengphong S, Khashab MA, Zhang G, McNamara G, Ewald AJ, Lin D, Liu Z, Meltzer SJ.

Cancer Lett. 2018 Nov 1;436:109-118. doi: 10.1016/j.canlet.2018.08.017. Epub 2018 Aug 23.

PMID:
30144514
14.

Inhibition of the miR-192/215-Rab11-FIP2 axis suppresses human gastric cancer progression.

Zhang X, Peng Y, Huang Y, Deng S, Feng X, Hou G, Lin H, Wang J, Yan R, Zhao Y, Fan X, Meltzer SJ, Li S, Jin Z.

Cell Death Dis. 2018 Jul 13;9(7):778. doi: 10.1038/s41419-018-0785-5.

15.

Research Gaps in Gestational Diabetes Mellitus: Executive Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Wexler DJ, Powe CE, Barbour LA, Buchanan T, Coustan DR, Corcoy R, Damm P, Dunne F, Feig DS, Ferrara A, Harper LM, Landon MB, Meltzer SJ, Metzger BE, Roeder H, Rowan JA, Sacks DA, Simmons D, Umans JG, Catalano PM.

Obstet Gynecol. 2018 Aug;132(2):496-505. doi: 10.1097/AOG.0000000000002726. Erratum in: Obstet Gynecol. 2018 Oct;132(4):1068.

16.

Health behaviour changes in partners of women with recent gestational diabetes: a phase IIa trial.

Brazeau AS, Meltzer SJ, Pace R, Garfield N, Godbout A, Meissner L, Rahme E, Da Costa D, Dasgupta K.

BMC Public Health. 2018 May 2;18(1):575. doi: 10.1186/s12889-018-5490-x.

17.

Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma.

Xie JJ, Jiang YY, Jiang Y, Li CQ, Lim MC, An O, Mayakonda A, Ding LW, Long L, Sun C, Lin LH, Chen L, Wu JY, Wu ZY, Cao Q, Fang WK, Yang W, Soukiasian H, Meltzer SJ, Yang H, Fullwood M, Xu LY, Li EM, Lin DC, Koeffler HP.

Gastroenterology. 2018 Jun;154(8):2137-2151.e1. doi: 10.1053/j.gastro.2018.02.018. Epub 2018 Feb 15.

PMID:
29454790
18.

SMG-1 inhibition by miR-192/-215 causes epithelial-mesenchymal transition in gastric carcinogenesis via activation of Wnt signaling.

Zhang X, Peng Y, Huang Y, Yang M, Yan R, Zhao Y, Cheng Y, Liu X, Deng S, Feng X, Lin H, Yu H, Chen S, Zhao Z, Li S, Li K, Wang L, Wei Y, He Z, Fan X, Meltzer SJ, Li S, Jin Z.

Cancer Med. 2018 Jan;7(1):146-156. doi: 10.1002/cam4.1237. Epub 2017 Dec 13.

19.

Esophageal Adenocarcinoma-Derived Extracellular Vesicle MicroRNAs Induce a Neoplastic Phenotype in Gastric Organoids.

Ke X, Yan R, Sun Z, Cheng Y, Meltzer A, Lu N, Shu X, Wang Z, Huang B, Liu X, Wang Z, Song JH, Ng CK, Ibrahim S, Abraham JM, Shin EJ, He S, Meltzer SJ.

Neoplasia. 2017 Nov;19(11):941-949. doi: 10.1016/j.neo.2017.06.007. Epub 2017 Sep 29.

20.

Choosing the Best Therapy for Your Patients in Today's Diabetes World.

Meltzer SJ, Yale JF.

Can J Diabetes. 2017 Oct;41(5):465-466. doi: 10.1016/j.jcjd.2017.08.002. Epub 2017 Aug 23. No abstract available.

PMID:
28843473
21.

Determination of absolute expression profiles using multiplexed miRNA analysis.

Song Y, Kilburn D, Song JH, Cheng Y, Saeui CT, Cheung DG, Croce CM, Yarema KJ, Meltzer SJ, Liu KJ, Wang TH.

PLoS One. 2017 Jul 13;12(7):e0180988. doi: 10.1371/journal.pone.0180988. eCollection 2017.

22.

RNA sequencing of esophageal adenocarcinomas identifies novel fusion transcripts, including NPC1-MELK, arising from a complex chromosomal rearrangement.

Wang Z, Cheng Y, Abraham JM, Yan R, Liu X, Chen W, Ibrahim S, Schroth GP, Ke X, He Y, Meltzer SJ.

Cancer. 2017 Oct 15;123(20):3916-3924. doi: 10.1002/cncr.30837. Epub 2017 Jun 22.

23.

Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.

Eluri S, Parian AM, Limketkai BN, Ha CY, Brant SR, Dudley-Brown S, Efron JE, Fang SG, Gearhart SL, Marohn MR, Meltzer SJ, Bashar S, Truta B, Montgomery EA, Lazarev MG.

Dig Dis Sci. 2017 Dec;62(12):3586-3593. doi: 10.1007/s10620-017-4652-5. Epub 2017 Jun 19.

24.

Long Noncoding RNAs in the Pathogenesis of Barrett's Esophagus and Esophageal Carcinoma.

Abraham JM, Meltzer SJ.

Gastroenterology. 2017 Jul;153(1):27-34. doi: 10.1053/j.gastro.2017.04.046. Epub 2017 May 18. Review.

25.

Gastric Cancer in the Era of Precision Medicine.

Liu X, Meltzer SJ.

Cell Mol Gastroenterol Hepatol. 2017 Feb 20;3(3):348-358. doi: 10.1016/j.jcmgh.2017.02.003. eCollection 2017 May. Review.

26.

Radiofrequency Ablation of Barrett's Esophagus Reduces Esophageal Adenocarcinoma Incidence and Mortality in a Comparative Modeling Analysis.

Kroep S, Heberle CR, Curtius K, Kong CY, Lansdorp-Vogelaar I, Ali A, Wolf WA, Shaheen NJ, Spechler SJ, Rubenstein JH, Nishioka NS, Meltzer SJ, Hazelton WD, van Ballegooijen M, Tramontano AC, Gazelle GS, Luebeck EG, Inadomi JM, Hur C.

Clin Gastroenterol Hepatol. 2017 Sep;15(9):1471-1474. doi: 10.1016/j.cgh.2016.12.034. Epub 2017 Jan 12. No abstract available.

27.

The novel fusion transcript NR5A2-KLHL29FT is generated by an insertion at the KLHL29 locus.

Sun Z, Ke X, Salzberg SL, Kim D, Antonescu V, Cheng Y, Huang B, Song JH, Abraham JM, Ibrahim S, Tian H, Meltzer SJ.

Cancer. 2017 May 1;123(9):1507-1515. doi: 10.1002/cncr.30510. Epub 2017 Jan 12.

28.

Proton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett's Esophagus: A Systematic Review and Meta-Analysis.

Hu Q, Sun TT, Hong J, Fang JY, Xiong H, Meltzer SJ.

PLoS One. 2017 Jan 10;12(1):e0169691. doi: 10.1371/journal.pone.0169691. eCollection 2017. Review.

29.

MiRNA-194 activates the Wnt/β-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU.

Peng Y, Zhang X, Ma Q, Yan R, Qin Y, Zhao Y, Cheng Y, Yang M, Wang Q, Feng X, Huang Y, Huang W, Zhao Z, Wang L, Wei Y, He Z, Fan X, Li S, Jin Z, Meltzer SJ.

Cancer Lett. 2017 Jan 28;385:117-127. doi: 10.1016/j.canlet.2016.10.035. Epub 2016 Oct 31.

PMID:
27810403
30.

Paf15 expression correlates with rectal cancer prognosis, cell proliferation and radiation response.

Yan R, Zhu K, Dang C, Lan K, Wang H, Yuan D, Chen W, Meltzer SJ, Li K.

Oncotarget. 2016 Jun 21;7(25):38750-38761. doi: 10.18632/oncotarget.9606.

31.

Leaky transporters and sphincters in Barrett's oesophagus?

Meltzer SJ.

Lancet Oncol. 2016 Oct;17(10):1336-1337. doi: 10.1016/S1470-2045(16)30365-5. Epub 2016 Aug 12. No abstract available.

32.

Extracellular vesicles carry microRNA-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model.

Li L, Piontek K, Ishida M, Fausther M, Dranoff JA, Fu R, Mezey E, Gould SJ, Fordjour FK, Meltzer SJ, Sirica AE, Selaru FM.

Hepatology. 2017 Feb;65(2):501-514. doi: 10.1002/hep.28735. Epub 2016 Aug 29.

33.

TNFAIP8 overexpression: a potential predictor of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor Lewis esophagectomy.

Sun Z, Liu X, Song JH, Cheng Y, Liu Y, Jia Y, Meltzer SJ, Wang Z.

Tumour Biol. 2016 Aug;37(8):10923-34. doi: 10.1007/s13277-016-4978-1. Epub 2016 Feb 17.

PMID:
26886285
34.

Long non-coding antisense RNA KRT7-AS is activated in gastric cancers and supports cancer cell progression by increasing KRT7 expression.

Huang B, Song JH, Cheng Y, Abraham JM, Ibrahim S, Sun Z, Ke X, Meltzer SJ.

Oncogene. 2016 Sep 15;35(37):4927-36. doi: 10.1038/onc.2016.25. Epub 2016 Feb 15.

35.

Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers.

Robles AI, Traverso G, Zhang M, Roberts NJ, Khan MA, Joseph C, Lauwers GY, Selaru FM, Popoli M, Pittman ME, Ke X, Hruban RH, Meltzer SJ, Kinzler KW, Vogelstein B, Harris CC, Papadopoulos N.

Gastroenterology. 2016 Apr;150(4):931-43. doi: 10.1053/j.gastro.2015.12.036. Epub 2016 Jan 5.

36.

Integrated miRNA profiling and bioinformatics analyses reveal potential causative miRNAs in gastric adenocarcinoma.

Zhang X, Peng Y, Jin Z, Huang W, Cheng Y, Liu Y, Feng X, Yang M, Huang Y, Zhao Z, Wang L, Wei Y, Fan X, Zheng D, Meltzer SJ.

Oncotarget. 2015 Oct 20;6(32):32878-89. doi: 10.18632/oncotarget.5419.

37.

TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling.

Ke X, Zhao Y, Lu X, Wang Z, Liu Y, Ren M, Lu G, Zhang D, Sun Z, Xu Z, Song JH, Cheng Y, Meltzer SJ, He S.

Oncotarget. 2015 Oct 20;6(32):32610-21. doi: 10.18632/oncotarget.5362.

38.

LINE-1 expression and retrotransposition in Barrett's esophagus and esophageal carcinoma.

Doucet-O'Hare TT, Rodić N, Sharma R, Darbari I, Abril G, Choi JA, Young Ahn J, Cheng Y, Anders RA, Burns KH, Meltzer SJ, Kazazian HH Jr.

Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):E4894-900. doi: 10.1073/pnas.1502474112. Epub 2015 Aug 17. Erratum in: Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):E104.

39.

Klotho: a tumor suppressor and modulator of the Wnt/β-catenin pathway in human hepatocellular carcinoma.

Tang X, Wang Y, Fan Z, Ji G, Wang M, Lin J, Huang S, Meltzer SJ.

Lab Invest. 2016 Feb;96(2):197-205. doi: 10.1038/labinvest.2015.86. Epub 2015 Aug 3. Review.

40.

Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia.

Bennett C, Moayyedi P, Corley DA, DeCaestecker J, Falck-Ytter Y, Falk G, Vakil N, Sanders S, Vieth M, Inadomi J, Aldulaimi D, Ho KY, Odze R, Meltzer SJ, Quigley E, Gittens S, Watson P, Zaninotto G, Iyer PG, Alexandre L, Ang Y, Callaghan J, Harrison R, Singh R, Bhandari P, Bisschops R, Geramizadeh B, Kaye P, Krishnadath S, Brian Fennerty M, Manner H, Nason KS, Pech O, Konda V, Ragunath K, Rahman I, Romero Y, Sampliner R, Siersema PD, Tack J, Tham TC, Trudgill N, Weinberg DS, Wang J, Wang K, Wong JY, Attwood S, Malfertheiner P, MacDonald D, Barr H, Ferguson MK, Jankowski J; BOB CAT Consortium.

Am J Gastroenterol. 2015 Jun;110(6):943. doi: 10.1038/ajg.2015.151. No abstract available.

PMID:
26052782
41.

Phosphorus-32, a clinically available drug, inhibits cancer growth by inducing DNA double-strand breakage.

Cheng Y, Kiess AP, Herman JM, Pomper MG, Meltzer SJ, Abraham JM.

PLoS One. 2015 Jun 1;10(6):e0128152. doi: 10.1371/journal.pone.0128152. eCollection 2015.

42.

BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia.

Bennett C, Moayyedi P, Corley DA, DeCaestecker J, Falck-Ytter Y, Falk G, Vakil N, Sanders S, Vieth M, Inadomi J, Aldulaimi D, Ho KY, Odze R, Meltzer SJ, Quigley E, Gittens S, Watson P, Zaninotto G, Iyer PG, Alexandre L, Ang Y, Callaghan J, Harrison R, Singh R, Bhandari P, Bisschops R, Geramizadeh B, Kaye P, Krishnadath S, Fennerty MB, Manner H, Nason KS, Pech O, Konda V, Ragunath K, Rahman I, Romero Y, Sampliner R, Siersema PD, Tack J, Tham TC, Trudgill N, Weinberg DS, Wang J, Wang K, Wong JY, Attwood S, Malfertheiner P, MacDonald D, Barr H, Ferguson MK, Jankowski J; BOB CAT Consortium.

Am J Gastroenterol. 2015 May;110(5):662-82; quiz 683. doi: 10.1038/ajg.2015.55. Epub 2015 Apr 14. Review. Erratum in: Am J Gastroenterol. 2015 Jun;110(6):943.

43.

Tumor suppression by miR-31 in esophageal carcinoma is p21-dependent.

Ning Z, Zhu H, Li F, Liu Q, Liu G, Tan T, Zhang B, Chen S, Li G, Huang D, Meltzer SJ, Zhang H.

Genes Cancer. 2014 Nov;5(11-12):436-44.

44.

Differential methylation of the promoter and first exon of the RASSF1A gene in hepatocarcinogenesis.

Jain S, Xie L, Boldbaatar B, Lin SY, Hamilton JP, Meltzer SJ, Chen SH, Hu CT, Block TM, Song W, Su YH.

Hepatol Res. 2015 Nov;45(11):1110-23. doi: 10.1111/hepr.12449. Epub 2014 Dec 9.

45.

Unhealthy lifestyles and gestational diabetes.

Meltzer SJ.

BMJ. 2014 Sep 30;349:g5549. doi: 10.1136/bmj.g5549. No abstract available.

PMID:
25270049
46.

Group-based activities with on-site childcare and online support improve glucose tolerance in women within 5 years of gestational diabetes pregnancy.

Brazeau AS, Leong A, Meltzer SJ, Cruz R, DaCosta D, Hendrickson-Nelson M, Joseph L, Dasgupta K; MoMM study group.

Cardiovasc Diabetol. 2014 Jun 30;13:104. doi: 10.1186/1475-2840-13-104.

47.

Temporal evolution in caveolin 1 methylation levels during human esophageal carcinogenesis.

Jin Z, Wang L, Cao Z, Cheng Y, Gao Y, Feng X, Chen S, Yu H, Wu W, Zhao Z, Dong M, Zhang X, Liu J, Fan X, Mori Y, Meltzer SJ.

BMC Cancer. 2014 May 20;14:345. doi: 10.1186/1471-2407-14-345.

48.

Genome-wide and gene-specific epigenomic platforms for hepatocellular carcinoma biomarker development trials.

Michailidi C, Soudry E, Brait M, Maldonado L, Jaffe A, Ili-Gangas C, Brebi-Mieville P, Perez J, Kim MS, Zhong X, Yang Q, Valle B, Meltzer SJ, Torbenson M, Esteller M, Sidransky D, Guerrero-Preston R.

Gastroenterol Res Pract. 2014;2014:597164. doi: 10.1155/2014/597164. Epub 2014 Apr 17.

49.

Strategies for implementing the WHO diagnostic criteria and classification of hyperglycaemia first detected in pregnancy.

Colagiuri S, Falavigna M, Agarwal MM, Boulvain M, Coetzee E, Hod M, Meltzer SJ, Metzger B, Omori Y, Rasa I, Schmidt MI, Seshiah V, Simmons D, Sobngwi E, Torloni MR, Yang HX.

Diabetes Res Clin Pract. 2014 Mar;103(3):364-72. doi: 10.1016/j.diabres.2014.02.012. Epub 2014 Feb 25.

PMID:
24731475
50.

In-hospital diabetes management.

Cheng AY, Houlden RL, Meltzer SJ.

Can J Diabetes. 2014 Apr;38(2):71-2. doi: 10.1016/j.jcjd.2014.02.003. No abstract available.

PMID:
24690498

Supplemental Content

Loading ...
Support Center